• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Vaccines / HPV / Dr. Sin Hang Lee recommends China postpone HPV vaccinations

Dr. Sin Hang Lee recommends China postpone HPV vaccinations

August 22, 2016 By admin 8 Comments

SaneVax-FeaturedBy Norma Erickson, SaneVax Inc.

Leading pathologist, Dr. Sin Hang Lee, sent an open letter to the President and Premier of China asking for a delay in the scheduled HPV vaccination of Chinese children and young women ages 9-25.

China’s population consists of approximately 143 million females age 9-25 [1]. If human papillomavirus (HPV) vaccine manufacturers can convince the Chinese government to vaccinate every woman in this age group with 3 doses of HPV vaccine via a Publicly Funded Program as proposed by two of their paid consultants [2], the revenue generated could amount to over $64 billion USD (using price of HPV vaccines sold in the USA at $150/dose). This staggering amount of money would provide an enormous impact to their bottom line. But the question is at what cost?

GlaxoSmithKline (GSK) became one step closer to achieving this when they announced on July 18, 2016 they had successfully persuaded the China Food and Drug Administration (CFDA) to license Cervarix™ as the first HPV vaccine to help prevent cervical cancer in China. According to the GSK announcement, the commercial launch of Cervarix™ in China is expected in early 2017. (Read the announcement here.)

Dr. Sin Hang Lee
Dr. Sin Hang Lee

The imminent implementation of mass HPV vaccination of Chinese children and young women age 9 to 25 has caused grave concerns among many informed citizens in China and abroad. One of those most concerned is Sin Hang Lee, MD, a Chinese American who received his formal medical education and training in China. Dr. Lee has practiced diagnostic cancer pathology in North America for more than 50 years with extensive experience in testing HPV DNA in patient samples and the HPV vaccine Gardasil®

Based on his knowledge of the health impacts of HPV vaccines he has considerable concerns for the female population of China. This prompted Dr. Lee to write an open letter to President Xi Jinping and Premier Li Keqiang of The People’s Republic of China, asking them to use their power to delay implementation of any HPV vaccination program in China until the risks versus benefits of mass HPV vaccination of the Chinese children and young women are adequately evaluated by independent medical/scientific experts. Importantly he believes it is essential that these experts are not financially connected to either the manufacturers or other HPV vaccine stakeholders.

In his open letter, Dr. Lee raises following serious science-based concerns about the proposed HPV vaccine program:

  1. There is zero scientific evidence that HPV vaccines have been proven to prevent a single case of cervical cancer in any country,
  2. To promote the vaccine, GSK created an unnecessary cervical cancer scare to create a market based on fear and not fact,
  3. Due to genetic difference, the HPV vaccines which were originally developed and tested in South America may not work across diverse Chinese ethnic populations,
  4. Long established and low cost cervical screening, not vaccination, is a proven safe and effective means of controlling cervical cancer and as such should be the number one health program, saving billions of dollars and countless lives.
  5. HPV vaccination offers no added value to existing cervical cancer screening programs,
  6. Globally there are 10’s of thousands of serious adverse reactions, including deaths, following HPV vaccination, and

7:  Vaccine manufacturers have inappropriately used their proprietary highly immunogenicity-enhancing aluminum adjuvant as the placebo in all clinical trials and to do in effect masks the risk of HPV vaccines.

The concerns that Dr. Lee has about HPV vaccination apply in other countries, where a number of inquiries are underway as to safety and efficacy and vaccination programs have been halted.

Read Dr. Lee’s Open Letter posted by Mr. I-wan Chen, a Policy Consultant in the People’s Republic of China, provided here.

Read Dr. Lee’s original letter here.

Read an executive summary Dr. Lee sent to China here.

Read this article in Croatian here.

Read this article in French here.

 

References:

[1] Demographics of China 2015. https://en.wikipedia.org/wiki/Demographics_of_China#Population_of_China_by_age_and_sex_.28demographic_pyramid.29

[2] Castle PE, Zhao FH. Population effectiveness, not efficacy, should decide who gets vaccinated against human papillomavirus via publicly funded programs. J Infect Dis. 2011;204:335-7.

Related

Filed Under: Cervarix, China, GlaxoSmithKline, HPV, SANE Vax Press Releases Tagged With: cervarix, China, Dr. Sin Hang Lee, HPV vaccinations

Comments

  1. Adesuyi Omoare says

    March 7, 2018 at 12:37 pm

    How Can i get Dr Sin Hang Lee’s cutting edge HPV DNA positive Control, Chlamydia trachomatis positive DNA control alongside their primers for my work on HPV and Chlamydia trachomatis co-infection among women in Nigeria.
    Thanks.

    Reply

Trackbacks

  1. Dr. Sin Hang Lee recommends China postpone HPV vaccinations | Health Exchange says:
    August 23, 2016 at 7:05 am

    […] Norma Erickson SaneVax […]

    Reply
  2. Dr. Sin Hang Lee recommends China postpone HPV vaccinations | Health Exchange says:
    August 23, 2016 at 7:05 am

    […] Norma Erickson SaneVax […]

    Reply
  3. Dr. Sin Hang Lee predlaže Kinezima da odgode primjenu HPV cjepiva | Cijepljenje.info says:
    August 27, 2016 at 12:06 pm

    […] 1. https://sanevax.org/dr-lee-recommends-china-postpone-hpv-vaccinations/ […]

    Reply
  4. Dr. Sin Hang Lee recommends China postpone HPV vaccinations | Boomer Health Report says:
    August 29, 2016 at 12:42 am

    […] By Norma Erickson […]

    Reply
  5. Vacuna del papiloma: China comenzará a vacunar con lo que rechazó Japón | Arsenal Terapéutico says:
    September 3, 2016 at 11:13 am

    […] cantidad asombrosa de dinero proporcionaría un enorme impacto económico. Pero la pregunta es ¿a qué costo?Esperamos realmente que las figuras políticas de alto nivel en China tomen nota de esto y empiecen […]

    Reply
  6. HPV Contamination – The BMC says:
    January 16, 2017 at 5:28 am

    […] Dr. Sin Hang Lee recommends China postpone HPV vaccinations” […]

    Reply
  7. The Gardasil Vaccine—Bad Science, Great Promotion, Dangerous | The Crazz Files says:
    July 31, 2018 at 9:46 pm

    […] is no proof that any of the HPV vaccines have ever prevented a single case of cervical cancer. But there is […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Our Family’s Roller Coaster Ride: Courtesy of Gardasil

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

CERVARIX VACCINE GSK’S PROMOTIONAL FLAWS

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2023 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in

 

Loading Comments...